Earnings Call · Q1 FY2026·2026-05-07

Q1 26EPS -5.56%·Rev n/aQ4 25EPS +2.86%·Rev n/aQ3 25EPS -6.25%·Rev n/aQ2 25EPS +5.26%·Rev n/a⚠ consensus missing

DiaMedica Therapeutics Inc. DMAC

Dietrich Pauls

Julie Krop — Chief Marketing Officer

Scott Kellen — CFO & Secretary

+0.2%1d on move date+0.5% vs SPY3d−1.1%5d−4.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DMAC calls or request research access.

More DMAC calls Browse calls Request research access